Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Mattei

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Drug Design, Development and Therapy|May 8, 2018
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLCYayi He, Sangtian Liu, Jane Mattei, et al.
Cancer Letters|November 19, 2013
Targeted therapy in metastatic renal carcinomaJane Mattei, Rodrigo Donalisio da Silva, David Sehrt, et al.
Life (Basel, Switzerland)|September 27, 2025
Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin CancerMarcio F Chedid, Aline C Tregnago, Floriano Riva, et al.
Urology|June 29, 2013
Male primary retroperitoneal mucinous cystadenomaJane Mattei, Fernando J Kim, Jason Phillips, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 22, 2021
Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to TreatmentMohammed Saleh, Sanaz Javadi, Sherif Elsherif, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 2022
Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to TreatmentMohammed Saleh, Sanaz Javadi, Sherif Elsherif, et al.
Melanoma Research|September 25, 2020
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanomaJane Mattei, Alexej Ballhausen, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2020
The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)Vivian Chua, Jane Mattei, Anna Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2012
Non-invasive breath analysis of pulmonary nodulesNir Peled, Meggie Hakim, Paul A Bunn, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
Volatile fingerprints of cancer specific genetic mutationsNir Peled, Orna Barash, Ulrike Tisch, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Drug Design, Development and Therapy|May 8, 2018
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLCYayi He, Sangtian Liu, Jane Mattei, et al.
Cancer Letters|November 19, 2013
Targeted therapy in metastatic renal carcinomaJane Mattei, Rodrigo Donalisio da Silva, David Sehrt, et al.
Life (Basel, Switzerland)|September 27, 2025
Indications and Mechanisms of Action of the Main Treatment Modalities for Non-Melanoma Skin CancerMarcio F Chedid, Aline C Tregnago, Floriano Riva, et al.
Urology|June 29, 2013
Male primary retroperitoneal mucinous cystadenomaJane Mattei, Fernando J Kim, Jason Phillips, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|October 22, 2021
Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to TreatmentMohammed Saleh, Sanaz Javadi, Sherif Elsherif, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 1, 2022
Multimodality Imaging and Genetics of Primary Mucosal Melanomas and Response to TreatmentMohammed Saleh, Sanaz Javadi, Sherif Elsherif, et al.
Melanoma Research|September 25, 2020
A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanomaJane Mattei, Alexej Ballhausen, Roland Bassett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 16, 2020
The Latest on Uveal Melanoma Research and Clinical Trials: Updates from the Cure Ocular Melanoma (CURE OM) Science Meeting (2019)Vivian Chua, Jane Mattei, Anna Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2012
Non-invasive breath analysis of pulmonary nodulesNir Peled, Meggie Hakim, Paul A Bunn, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
Volatile fingerprints of cancer specific genetic mutationsNir Peled, Orna Barash, Ulrike Tisch, et al.
Pageof 3